John Parkinson is the assistant managing editor for Contagion. Prior to joining MJH Life Sciences in 2020, he has covered a variety of fields and markets including diabetes, oncology, ophthalmology, IT, travel, and local news. You can email him at jparkinson@mjhlifesciences.com.
FDA Expands Indication for AbbVie’s Antiviral as First Treatment for People With Acute Hepatitis C
June 13th 2025The antiviral, glecaprevir/pibrentasvir (Mavyet), is the first and only oral 8-week pangenotypic treatment approved for people with acute or chronic hepatitis C. The approval supports global clinical guidelines to advance testing and treatment HCV regardless of chronicity, and supports public health goals for disease elimination.
Read More
Federal Government Changes Course Again on COVID-19 Vaccine Policy
June 2nd 2025After the leaders of the NIH, FDA, and HHS made an announcement stating that both pregnant women and children were going to be taken off the COVID-19 immunization schedule, they decided to offer a new designation for the latter group, making it a shared decision between providers and patients.
Read More
Company Receives NIH Grant For Novel Investigational Antibiotic to Combat ‘Super Gonorrhea’
May 27th 2025TAXIS Pharmaceuticals announced it received a $2.9 million dollar federal grant, which will allow the company to further advance its efforts with its dihydrofolate reductase inhibitors (DHFRIs) for the rapidly spreading and antibiotic-resistant strain of Neisseria gonorrhoeae.
Read More
How Will the New FDA COVID-19 Vaccine Policy Affect the Pediatric Population?
May 22nd 2025Pediatrician Sharon Nachman, MD, discusses the potential effects of the new policy including how things like vaccine access, incidence rates, and participation in placebo-controlled trials may change.
Read More
Ceftobiprole Launches Commercially in US
May 20th 2025Innoviva Specialty Therapeutics’ antibiotic is the first and only FDA-approved cephalosporin indicated to treat Staphylococcus aureus bacteremia, including right-sided endocarditis, caused by the methicillin-resistant Staphylococcus aureus.
Read More
Handwashing: An Infection Prevention Method That We Forget?
May 15th 2025Robert Hopkins Jr, MD, the medical director of the National Foundation for Infectious Diseases discusses the results of the organization's new survey and the surprising findings that many people forget to wash their hands after key times or believe it is not needed.
Read More
New Report Calls For Funding Treatments, Greater Emphasis on Chronic Lyme Disease
May 14th 2025A small percentage of people who contract the tick-borne illness have lingering symptoms and health issues after the acute infection has been treated, but there are no FDA-approved therapies to deal with prolonged symptoms. A new report looks to address this issue.
Read More
Pertussis: Another Vaccine-Preventable Disease Seeing a Major Resurgence
May 14th 2025Pertussis, also known as whooping cough, saw more cases last year than in the last decade, and it is on track for another record year for cases. Sharon Nachman, MD, provides clinical insights for presentation, treatment, and vaccination.
Read More